NCT01896011View on ClinicalTrials.gov

Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Non Displaced Atypical Femoral Fractures
Interventions
BIOLOGICAL

Teriparatide 20 mcg

Teriparatide 20 mcg injection pen

OTHER

Placebo

Placebo 20 mcg injection pen

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

collaborator

Eli Lilly and Company

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT01896011 - Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures | Biotech Hunter | Biotech Hunter